BlackRock Investment Management, LLC - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2016$286,000
-31.9%
71,4140.0%0.00%
-100.0%
Q3 2016$420,000
+7.1%
71,414
-0.3%
0.00%
Q2 2016$392,00071,6030.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q1 2017
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 62,219$340,0000.16%
THOMPSON DAVIS & CO., INC. 16,184$89,0000.14%
Blume Capital Management, Inc. 2,546$14,0000.01%
BLUESTEIN R H & CO LLC 20,000$109,0000.01%
Virtu KCG Holdings LLC 49,157$269,0000.01%
Spark Investment Management LLC 11,000$60,0000.01%
Spot Trading L.L.C 62,300$341,0000.01%
Acrospire Investment Management LLC 1,270$7,0000.01%
ACCURATE INVESTMENT SOLUTIONS, INC. 1,000$5,0000.01%
ARCADIA INVESTMENT MANAGEMENT CORP/MI 1,819$10,0000.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders